Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin

P. Alberti, E. Rossi, D. R. Cornblath, I. S J Merkies, T. J. Postma, B. Frigeni, J. Bruna, R. Velasco, A. A. Argyriou, H. P. Kalofonos, D. Psimaras, D. Ricard, A. Pace, E. Galiè, C. Briani, C. Dalla Torre, C. G. Faber, R. I. Lalisang, W. Boogerd, D. BrandsmaS. Koeppen, J. Hense, D. Storey, S. Kerrigan, A. Schenone, S. Fabbri, M. G. Valsecchi, G. Cavaletti

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been fully addressed, although these two approaches might eventually lead to inconsistent, possibly conflicting interpretation, especially regarding sensory impairment. Patients and methods: A cohort of 281 subjects with stable CIPN was evaluated with the National Cancer Institute- Common Toxicity Criteria (NCI-CTC v. 2.0) sensory scale, the clinical Total Neuropathy Score (TNSc

Original languageEnglish
Article numbermdt409
Pages (from-to)257-264
Number of pages8
JournalAnnals of Oncology
Volume25
Issue number1
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Oncology
  • Hematology

Fingerprint

Dive into the research topics of 'Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: Two sides of the same coin'. Together they form a unique fingerprint.

Cite this